SCHEMBL9090184

SCHEMBL9090184

CCCCCCn1cc(NC(=O)c2c(F)cccc2C(=O)O)nc1CC(=O)OCC

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ PTPN1 P18031 1/20 0.41
▸ CNR2 P34972 7/20 0.38
▸ CNR1 P21554 4/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ AGTR1 P30556 1/20 0.38
▸ AGTR2 P50052 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.37
▸ PLK1 P53350 1/20 0.37
▸ PLK3 Q9H4B4 1/20 0.37
▸ MEN1 O00255 3/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ HTT P42858 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ PKM P14618 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9090036 0.88 AGTR1 (0.42) CNR2CNR1AGTR1AGTR2KDM4E
SCHEMBL9090111 0.86 ALDH1A1 (0.48) CNR2CNR1CYP1A2AGTR1AGTR2
SCHEMBL7049616 0.86 AGTR1 (0.53) PTPN1CNR2CNR1AGTR1AGTR2
SCHEMBL9091321 0.85 CNR2 (0.42) CNR2CNR1KDM4EMEN1KMT2A
SCHEMBL9090908 0.84 AGTR1 (0.41) PTPN1CNR2CNR1AGTR1AGTR2
SCHEMBL9090903 0.83 NAAA (0.43) CNR2CNR1NPC1RAB9AAGTR1
SCHEMBL9089034 0.83 KDM4E (0.43) CNR2CNR1KDM4EMEN1KMT2A
SCHEMBL9091491 0.82 KDM4E (0.38) CNR2CNR1CYP1A2KDM4EMEN1
SCHEMBL9090145 0.82 TLR8 (0.39) CNR2CNR1NPC1RAB9AAGTR1
SCHEMBL9091009 0.79 PDE4A (0.40) CNR2CNR1NPC1RAB9ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5571925-A HORMONES INHIBITORS FOR HYPOTENSIVE AGENTS ELI LILLY AND COMPANY (US) 1996-11-05 — — US disclosed
US-5563278-A Angiotensin II antagonists ELI LILLY AND COMPANY (US) 1996-10-08 — — US disclosed
EP-0438869-B1 Improvements in and relating to angiotensin II antagonists LILLY CO ELI (US) 1994-12-14 — — EP disclosed
US-5312936-A Hypotensive agents ELI LILLY AND COMPANY (US) 1994-05-17 — — US disclosed
US-5073566-A Hypotensive agents ELI LILLY AND COMPANY (US) 1991-12-17 — — US disclosed
EP-0438869-A1 Improvements in and relating to angiotensin II antagonists ELI LILLY AND COMPANY (US) 1991-07-31 — — EP disclosed
Send feedback